{
    "code": "02024630",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024630",
    "time": "2023-08-10 19:24:03",
    "許可證字號": "衛署藥輸字第024630號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/03\/28",
    "發證\/登錄日期": "96\/03\/28",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202463006",
    "中文品名": "骨維壯注射劑",
    "英文品名": "Bonviva 3mg\/3ml solution for injection",
    "適應症": "用於治療停經後婦女之骨質疏鬆症(BMD TSCORE < -2.5 SD)，以減少脊椎骨骨折。",
    "劑型": "270注射劑",
    "包裝": "3mL預填充注射針筒 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "MONOSODIUM IBANDRONATE MONOHYDRATE",
    "限制項目": "02輸　入 55依本署89、12、12衛署藥字第0890035812號公告事項三經本署認定得免除銜接性試驗之新藥",
    "申請商名稱": "和聯生技藥業股份有限公司",
    "申請商地址": "台北市敦化北路３１１號５樓",
    "主製造廠": [
        {
            "製造廠名稱": "VETTER PHARMA-FERTIGUNG GMBH &amp; CO. KG",
            "製造廠廠址": "EISENBAHNSTRASSE 2-4, 88085 LANGENARGEN GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "委託製造者"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "Waymade PLC",
            "製造廠廠址": "Sovereign House, Miles Gray Road, Basildon, Essex SS14 3FR United Kingdon",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "Atnahs Pharma UK Ltd",
            "製造廠廠址": "Sovereign House, Miles Gray Road, Basildon, Essex, SS14 3FR, United Kingdom",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6400001710",
            "成分名稱": "MONOSODIUM IBANDRONATE MONOHYDRATE",
            "含量描述": "",
            "含量": "3.3750000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "020246300004-Bonviva Inj. -藥物實體照片-104-09-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024630&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Bonviva 3mg3ml 1 asrg 703-9555 TW Leaflet V2-2023.07.14-112-07-14(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024630&Seq=007&Type=9"
        },
        {
            "title": "骨維壯注射劑Bonviva Injection衛署藥輸字第024630號中文仿單-109-11-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024630&Seq=006&Type=9"
        },
        {
            "title": "02-024630_仿單Bonviva Injection-109-06-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024630&Seq=005&Type=9"
        },
        {
            "title": "骨維壯注射劑Bonviva Injection衛署藥輸字第024630號標籤-109-11-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024630&Seq=013&Type=8"
        },
        {
            "title": "02-024630_標籤Bonviva Injection Label-109-06-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024630&Seq=011&Type=8"
        },
        {
            "title": "02-024630_外盒Bonviva Injection-109-06-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024630&Seq=010&Type=8"
        }
    ]
}